Seoul Pharma Co., Ltd (KOSDAQ: 018680)

Seoul Pharma Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2011	FY 2010	FY 2009	FY 2008	FY 2007
Period Ending	Sep 30, 2012	Dec 31, 2011	Dec 31, 2010	Dec 31, 2009	Dec 31, 2008	Dec 31, 2007
Cash & Equivalents	3,187	2,549	667.94	832.27	1,645	1,224
Short-Term Investments	-	0.13	0.43	0.19	504.3	5.06
Cash & Short-Term Investments	3,187	2,549	668.36	832.46	2,149	1,229
Cash Growth	105.19%	281.45%	-19.71%	-61.27%	74.80%	-57.28%
Accounts Receivable	11,286	10,893	14,189	14,950	13,451	10,812
Other Receivables	187.45	53.92	104.44	51.04	33.97	23.66
Receivables	11,473	10,947	14,294	15,001	13,485	10,835
Inventory	4,861	4,867	4,240	3,045	2,147	2,003
Prepaid Expenses	233.7	33.38	9.74	21.51	16.87	236.6
Other Current Assets	324.8	231.03	1,170	1,001	531.08	556.65
Total Current Assets	20,080	18,628	20,382	19,901	18,416	14,861
Property, Plant & Equipment	32,584	20,135	15,809	13,853	6,297	4,900
Long-Term Investments	520.17	448.17	356.89	369.71	369.61	369.61
Other Intangible Assets	3,994	2,953	1,961	1,407	1,084	987.28
Long-Term Deferred Tax Assets	237.88	147.12	-	486.95	330.53	299.13
Long-Term Deferred Charges	-	-	-	289.6	105.8	-
Other Long-Term Assets	427.6	376.87	364.87	323.26	331.76	357.63
Total Assets	57,844	42,687	38,874	36,631	26,935	21,774
Accounts Payable	3,164	2,852	4,263	3,248	1,749	1,919
Accrued Expenses	847.59	912.53	667.25	485.56	763.06	600.52
Short-Term Debt	6,193	3,000	2,000	2,500	3,100	1,831
Current Portion of Long-Term Debt	4,494	2,577	1,101	1,100	-	-
Current Income Taxes Payable	-	29.69	9.36	145.98	-	-
Current Unearned Revenue	80	200	403.9	754.83	403.97	127.31
Other Current Liabilities	1,447	707.36	867.04	1,200	863.39	759.08
Total Current Liabilities	16,225	10,278	9,311	9,762	6,880	5,252
Long-Term Debt	17,708	9,458	8,034	6,445	3,166	300
Long-Term Deferred Tax Liabilities	-	-	8.05	-	-	-
Other Long-Term Liabilities	282.59	482.09	498.49	700.99	647.3	903.38
Total Liabilities	36,803	22,305	19,464	18,449	11,839	7,343
Common Stock	3,150	3,125	3,125	3,125	3,125	3,125
Additional Paid-In Capital	4,438	4,251	3,886	2,127	2,127	2,127
Retained Earnings	13,447	12,969	12,015	8,932	7,751	7,209
Comprensive Income & Other	4.92	38.64	384.17	3,998	2,093	1,971
Shareholders' Equity	21,040	20,383	19,410	18,182	15,096	14,432
Total Liabilities & Equity	57,844	42,687	38,874	36,631	26,935	21,774
Total Debt	28,395	15,034	11,135	10,045	6,266	2,131
Net Cash (Debt)	-25,207	-12,485	-10,467	-9,212	-4,117	-901.52
Net Cash Per Share	-	-	-	-1473.97	-658.76	-144.24
Filing Date Shares Outstanding	6.3	6.25	6.25	6.25	6.25	6.25
Total Common Shares Outstanding	6.3	6.25	6.25	6.25	6.25	6.25
Working Capital	3,855	8,350	11,071	10,139	11,536	9,609
Book Value Per Share	3339.71	3261.25	3105.62	2909.12	2415.30	2309.09
Tangible Book Value	17,047	17,430	17,449	16,775	14,011	13,445
Tangible Book Value Per Share	2705.80	2788.82	2791.79	2684.07	2241.82	2151.13
Land	-	-	-	2,961	563.02	563.02
Buildings	-	-	-	6,837	3,086	3,073
Machinery	-	-	-	6,893	6,419	5,657
Construction In Progress	-	-	-	4,256	2,665	1,176

Source: S&P Capital IQ. Standard template. Financial Sources.